Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Venue change for important Odeion School of Music event
2016-09-21

Due to the unforeseen closing of the campuses of the University of the Free State from 20 to 23 September 2016, substantial changes had to be made to the venues and schedules of The Liesbeth Schlumberger Organ Chair (presented by the Odeion School of Music at the UFS) and the Annual Southern African Church Organists Society (SAKOV) Meeting and Bursary Competition.

The event, scheduled for 22-29 September 2016, will now take place at the following venues:

Wednesday 21 September 2016
15:00-18:00 DRC Onze Rust Rehearsals SAKOV Bursary Candidates

Thursday 22 September 2016
08:00-21:00 DRC Onze Rust, Rehearsals SAKOV Bursary Candidates
14:00-16:30 DRC Langenhoven Park, Organ Marathon
17:30-18:30 Lutheran Church St Paulus, Liesbeth Schlumberger Concert
18:00-21:00 DRC Universitas SAKOV EXCOM Meeting
22:00 Sacred Heart Catholic Cathedral, Late Night Concert with works by Olivier Messiaen

Friday 23 September 2016
08:00-10:15 DRC Onze Rust, Bursary Candidates Competition
12:00-15:00 DRC Onze Rust, Bursary Candidates Competition
15:00-16:30 DRC Langenhoven Park Masterclass: Church music (Dr Jan Beukes)
17:00-19:00 DRC Universtas, SAKOV Regional Representatives Meeting
19:30 DRC Universtas, Liesbeth Schlumberger Gala Concert

Saturday 24 September 2016
DRC Langenhoven Park
08:00-08:30 Registration
08:30-09:00 Opening and singing, Rev Jaques Louw and Margaret van der Vegt
09:00-09:15 SAKOV Honorary membership award
09:15-10:00 General Assembly
10:00-11:00 G Cillié Memorial Lecture, Prof Elsabé Kloppers

Klinkende ruimte: Reformasie deur die kerklied

11:00-12:00 Lecture (Liesbeth Schlumberger): L'Art de Toucher / Die kuns van musikale aanslag/The Art of Touch
12:00-13:00 Lunch
14:30-17:00 Organ Safari, DRC Langenhoven Park starting point
19:30 DRC Onze Rust, SAKOV Bursary Gala Concert

Sunday 25 September 2016
Lutheran Church St Paulus 10:00
Morning Service accompanied by Liesbeth Schlumberger

Monday 26 to Thursday 29 September 2016
Masterclass series Liesbeth Schlumberger - Kurpershoek, Odeion School of Music

For any inquiries please contact Marius Coetzee on +27 51 401 3152, +27 72 338 2240 or CoetzeeML@ufs.ac.za.

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept